🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
COR
$CORT
🔒 US EquitiesCorcept Therapeutics Incorporat
AVG HISTORICAL GAP
+1.73%
MAX GAP RECORD
+20.49%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CORT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CORT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Jul 29, 2026 Earnings Release 2026-07-29 (AFTER CLOSE) |
+20.49%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
+4.21%
|
| Feb 24, 2026 Earnings Release 2026-02-24 (AFTER CLOSE) |
+3.21%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
-5.77%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (AFTER CLOSE) |
-3.60%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
-0.03%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE) |
-3.74%
|
| Oct 30, 2024 Earnings Release 2024-10-30 (AFTER CLOSE) |
-1.92%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.1%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗